Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ImmunoGen Company Profile (NASDAQ:IMGN)

Consensus Ratings for ImmunoGen (NASDAQ:IMGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $12.10 (98.04% upside)

Current Analysts' Coverage Summary for ImmunoGen (NASDAQ:IMGN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/19/2014Leerink SwannDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
12/19/2014Jefferies GroupDowngradeBuy -> Hold$20.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
11/3/2014Cowen and CompanyInitiated CoverageMarket Perform$8.50ViewTweet This Rating  Share This Rating on StockTwits
6/25/2014Morgan StanleyInitiated CoverageUnderweight$10.00ViewTweet This Rating  Share This Rating on StockTwits
4/16/2014Canaccord GenuityInitiated CoverageBuy -> Buy$20.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014GuggenheimBoost Price Target$14.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013RBC CapitalLower Price TargetOutperform$22.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Chardan CapitalReiterated RatingBuy$21.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2013Stifel NicolausDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
8/26/2013Roth CapitalInitiated CoverageBuy$19.00ViewTweet This Rating  Share This Rating on StockTwits
8/6/2013Credit SuisseBoost Price TargetNeutral$15.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013Cantor FitzgeraldBoost Price TargetHold$13.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013OppenheimerDowngradeOutperform -> Market Perform$14.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/22/2012 forward)